TTWO stock · XBIO stock

TTWO vs XBIO · rev $6.66B vs rev $1.5M

Take-Two Interactive Software Inc (TTWO) versus Xenetic Biosciences Inc (XBIO) — a side-by-side from cached financials, not a winner call.

Take-Two Interactive Software Inc (TTWO) is a electronic gaming & multimedia company listed on NASDAQ.

Xenetic Biosciences Inc (XBIO) is a biotechnology company listed on US.

Latest reported TTWO revenue for 2026-03-31 was $6.66B. Net income was -$298.2M. Revenue was up 18.2% from 2025-03-31 to 2026-03-31. TTWO currently screens at market cap $42.34B.

Latest reported XBIO revenue for 2026-06-30 was $1.5M. Net income was -$1.4M. Revenue was up 81.9% from 2026-03-31 to 2026-06-30. XBIO currently screens at market cap $5.7M.

TTWO currently screens at market cap $42.34B. XBIO currently screens at market cap $5.7M.

Not investment advice. Open the TTWO and XBIO stock pages for the full models.

Not investment advice.

Popular Stock Comparisons